A Study Of VYKATTM XR (Diazoxide Choline Extended-Release Tablets) For Hyperphagia In 4 Years Of Age And Older With Prader-Willi Syndrome (PWS)
Rochester, MN
The purpose of this study is to gain a better understanding of the safety profile, clinical characteristics, and outcomes in patients with Prader-Willi syndrome (PWS) treated with VYKAT XR in a real-world setting.